ST Pharm Co.,Ltd.

Informe acción KOSDAQ:A237690

Capitalización de mercado: ₩1.7t

ST PharmLtd Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Mooje Sung

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOless than a year
Participación del CEOn/a
Permanencia media de la dirección1.8yrs
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Should You Be Adding ST PharmLtd (KOSDAQ:237690) To Your Watchlist Today?

Nov 22
Should You Be Adding ST PharmLtd (KOSDAQ:237690) To Your Watchlist Today?

ST Pharm Co.,Ltd.'s (KOSDAQ:237690) Shares Climb 29% But Its Business Is Yet to Catch Up

Aug 30
ST Pharm Co.,Ltd.'s (KOSDAQ:237690) Shares Climb 29% But Its Business Is Yet to Catch Up

Is Now The Time To Put ST PharmLtd (KOSDAQ:237690) On Your Watchlist?

Aug 17
Is Now The Time To Put ST PharmLtd (KOSDAQ:237690) On Your Watchlist?

Is ST Pharm Co.,Ltd. (KOSDAQ:237690) Trading At A 41% Discount?

May 09
Is ST Pharm Co.,Ltd. (KOSDAQ:237690) Trading At A 41% Discount?

Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem

Mar 22
Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem

ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected

Mar 18
ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected

Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%

Mar 16
Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%

Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)

Jan 22
Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)

What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?

Dec 23
What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?

Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?

Nov 26
Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?

CEO

Mooje Sung

less than a year

Permanencia

Mooje Sung is Chief Executive Officer of ST Pharm Co. Ltd. from July 2024. Mooje Sung has Ph.D. in Organic Chemistry from University Of Alabama, M.S. in Organic Chemistry from Sogang University and has B.S...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Mooje Sung
Chief Executive Officerless than a yearsin datossin datos
Dong-Ryul Lee
Head of Management Support Division & Inside Directorno datasin datossin datos
Seok-Woo Choi
Senior Vice Presidentno datasin datos0.00024%
₩ 4.0m
Hyunmin Lee
Senior Vice Presidentno datasin datossin datos
Jun Young Choi
Senior Vice President3.9yrssin datos0.054%
₩ 903.6m
Sunki Chang
Senior Vice President1.8yrssin datossin datos
Joosung Yang
Senior Vice President1.8yrssin datos0.085%
₩ 1.4b
Kyungyeon Kim
Senior VP & Head of Corporate Quality Divisionno datasin datossin datos

1.8yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de A237690 no se considera experimentado ( 1.8 años antigüedad media), lo que sugiere un nuevo equipo.